Protocol to Obtain Blood and Bone Marrow Samples for Myeloma Research

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

29 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-08-31

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to collect a blood or bone marrow sample from patients with multiple myeloma and from volunteers without myeloma.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma

NCT00897910

Multiple Myeloma and Plasma Cell Neoplasm

TERMINATED

Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma

NCT03127761

Multiple Myeloma

RECRUITING

Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission

NCT04221178

Plasma Cell Myeloma

ACTIVE_NOT_RECRUITING

Multiple Myeloma Patient Registry

NCT03180853

Multiple Myeloma

TERMINATED

Patient and Care Partner Experiences Living With Multiple Myeloma (PaCE-MM)

NCT05276622

Multiple Myeloma

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The blood and bone marrow samples will be used in the laboratory to perform focused studies on multiple myeloma.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Myeloma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy Volunteers

Healthy volunteers who have agreed to have a bone marrow and/or blood harvest as part of a donation to a transplant recipient.

No interventions assigned to this group

Patients with multiple myeloma

Patients undergoing routine blood draw and bone marrow aspirates as part of their ongoing follow-up care for myeloma at the Norris Cotton Cancer Center of DHMC.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participant population is multiple myeloma patients over the age of 18 who are undergoing a scheduled bone marrow collection and/or blood drawing procedure as part of their routine treatment or follow up, and healthy volunteers over the age of 18 who have agreed to have a bone marrow and/or blood harvest as part of a donation to a transplant recipient.

Exclusion Criteria

* Patients, who in the opinion of their physician, would be adversely affected by removal of an extra15ml of blood and /or an extra 10ml of bone marrow.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes